Efavirenz receives FDA approval

被引：0

作者：

Dobkin, JF ^{[1
]}

机构：

[1] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA

来源：

INFECTIONS IN MEDICINE | 1998年 / 15卷 / 11期

关键词：

human immunodeficiency virus (HIV); acquired immune deficiency syndrome (AIDS); protease inhibitors; non-nucleoside reverse transcriptase inhibitors (NNRTIs); efavirenz;

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：747 / 747

页数：1

共 50 条

[1] Zelboraf Receives FDA Approval
不详
JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (10) : 1215 - 1215
[2] GELLAN GUM RECEIVES FDA APPROVAL
不详
FOOD TECHNOLOGY, 1990, 44 (11) : 88 - 90
[3] BTG RECEIVES FDA APPROVAL FOR HGH
不详
EUROPEAN CHEMICAL NEWS, 1995, 63 (1670): : 29 - 29
[4] Nivolumab Receives Expanded FDA Approval
Schuyler, Devon
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (11) : 738 - 738
[5] Liposuction laser receives FDA approval
不详
EXPERT REVIEW OF MEDICAL DEVICES, 2005, 2 (02) : 136 - 136
[6] Insulin glulisine receives FDA approval
Holt, RIG
DIABETES OBESITY & METABOLISM, 2004, 6 (05): : 397 - 397
[7] HUMAN INSULIN RECEIVES FDA APPROVAL
不详
CLINICAL PEDIATRICS, 1983, 22 (05) : 367 - 367
[8] New cancer appliance receives FDA approval
不详
AKTUELLE UROLOGIE, 2006, 37 (03) : 198 - 198
[9] Perindopril receives FDA approval for new indication
不详
DRUG NEWS & PERSPECTIVES, 2005, 18 (07) : 436 - 436
[10] Galderma Receives FDA Approval of Treatment for Rosacea
不详
JOURNAL OF DRUGS IN DERMATOLOGY, 2015, 14 (02) : 205 - 205

← 1 2 3 4 5 →